Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 984,648 | 672,617 | 1,017,386 | 1,480,231 | 779,709 |
| Marketable Securities | 960,723 | 1,015,200 | 971,764 | 546,950 | 359,987 |
| Receivables | 181,621 | 203,074 | 196,133 | 210,495 | 158,554 |
| Inventories | 79,647 | 52,688 | 34,061 | 21,675 | 23,194 |
| TOTAL | $2,273,948 | $2,007,803 | $2,272,875 | $2,316,406 | $1,365,531 |
| Non-Current Assets | |||||
| PPE Net | 55,371 | 56,970 | 57,189 | 59,459 | 60,970 |
| Intangibles | 471,094 | 478,807 | 226,147 | 200,789 | 201,135 |
| Other Non-Current Assets | 98,354 | 100,120 | 77,944 | 78,733 | 77,388 |
| TOTAL | $624,819 | $635,897 | $361,280 | $338,981 | $339,493 |
| Total Assets | $2,898,767 | $2,643,700 | $2,634,155 | $2,655,387 | $1,705,024 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 569,631 | 546,927 | 262,021 | 248,240 | 257,821 |
| Accounts payable and accrued liabilities | 381,272 | 303,141 | 338,945 | 317,807 | 304,292 |
| TOTAL | $968,427 | $866,245 | $627,809 | $595,391 | $580,981 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,025,366 | 1,821,313 | 2,119,998 | 2,135,935 | 2,109,367 |
| Deferred Revenues | 2,040 | 1,691 | 9,760 | 12,833 | 5,505 |
| Other Non-Current Liabilities | 107,287 | 98,067 | 79,061 | 95,988 | 97,173 |
| TOTAL | $2,135,653 | $1,933,213 | $2,212,892 | $2,245,756 | $2,222,114 |
| Total Liabilities | $3,104,080 | $2,799,458 | $2,840,701 | $2,841,147 | $2,803,095 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,775 | 80,288 | 79,438 | 79,257 | 78,869 |
| Common Shares | 80 | 79 | 78 | 78 | 77 |
| Retained earnings | -2,964,229 | -2,829,264 | -2,845,160 | -2,780,311 | -3,646,873 |
| Other shareholders' equity | 10,501 | 5,930 | 7,356 | -13,949 | -25,886 |
| TOTAL | $-205,313 | $-155,758 | $-206,546 | $-185,760 | $-1,098,071 |
| Total Liabilities And Equity | $2,898,767 | $2,643,700 | $2,634,155 | $2,655,387 | $1,705,024 |